Browse, Buy & Charities Benefit!
Cart 0

Stage 4 Cancer Statistics - Reaching Beyond Cancer Treatment Numbers and Statistically Improving Final Outcome

Stage 4 Cancer Statistics - Reaching Beyond Cancer Treatment Numbers and Statistically Improving Final Outcome

Most cancer and Stage 4 cancer patients will research results to aid in procurement of their optimal treatment facility. This article goes far beyond the stats, offering patients a thorough understanding of ways to evaluate their options and statistically improve their cancer outcomes.

Envita's decade plus of working with advanced and Stage 4 cancer's most complex cases is stellar to provide you with physician-direct perspective on comparing conventional and alternative cancer centers - and determining which is best for you.

Our approach concentrates on targeting therapies and treatments that regularly provide statistical and biological advantages for patients stricken with various cancer types.

Cancer Treatment Statistics Can be Deceiving

There are many reasons why "statistically significant" doesn't necessarily mean improvement in your situation. One must first determine whether the correct indicators are being examined in the provided survival data. For example, is "the response rate" offered for a specific cancer type's treatment regimen short-lived or augmented with significant improvement in life quality?

The real issue in that many of these cancer treatment "responses" can often be temporary, or perhaps even fleeting. Among patients with cancers of identical stage and type can there are various response rates based on the behavior and genetic variations of each person's tumors. This is an important item to consider as it relates to the model specifically used by cancer hospitals and drug companies - as you can determine, however, it manifests significant flaws.

The notion of response rates being deceptive closely mirrors a more fundamental problem with cancer statistics on average. Envita Medical Centers assures survival and overall quality of life for patients, our most tantamount measures of success.

Example of Static Problems in Cancer Treatment - Lets Prove the Point

Here is an example to demonstrate some of typical problems associated with a "statics based" response to cancer treatment:

Treatment Protocol 1 (TP1) has 35 percent rate of response while Treatment Protocol 2 (TP2) has a 75 percent rate. However, if we find TP2 is short-lived, it certainly does not mean that it is a better treatment. Moreover, if TP2 is significantly more toxic than TP1, it is likely that the quality of life for TP2 patients will be considerably less.

These games of data manipulation and "omitting parts of the summary," are often intended by pharmaceutical companies and cancer centers to attract patients.
Other cancer centers have adopted the approach of implementing with "special criteria" to favorably skew their results. For example, their provisional data may state "patients that completed our protocol." This is an indication that unscrupulous tactics were devised to create exclusionary criteria, thereby diminishing undesirable outcomes and appearing superior at a cavalier first glance.

Statics are regularly manipulated in abundant ways - it is not uncommon to see organizations emphasize enhanced results by including specious (or concealing relevant) survival data.

Without specific calculation criteria, results are candidly unreliable at best - making such criteria absolutely critical for objective comparison. Keep in mind, if it appears too good to be true, such generally is.

Statics That Matter: The Bottom Line Is - Patients Can Improve Their Stage 4 Cancer Statics and Save Their Lives 
In our experience, patients are seriously requesting the most favorable treatments available to produce remission, achieve a cure, and survive. That accentuates the bottom line.

So, exercise reasonable caution with the statistical data and white papers that you read. We have found that, no matter the size of the organization, the data provided by medical groups can be somewhat fraudulent and likely far more convoluted then they appear - particularly those sources made available online.

It is important to systematically consider both conventional and alternative medicine and articulate the true "game changers" that may statically and significantly help you to maximize your goal. Do not dismiss the fact that cancer is individualized and cannot be neatly arranged into broad categories of type and stage. This can be viewed in latest treatments for cancer being administered globally. Genetic and personalized immunotherapies are beginning to replace the ubiquitous models - because their results are superior.

Why is this evidenced? Undoubtedly because each patient is unique - including their respective cancer's causative agents, their tumor's specific metabolism, and even the way the patient diminishes side effects. It is without question that the future of cancer treatment is personalization, and Envita is foremost in leading the way.

Stage 4 Cancer Treatments Impact Statistics - Conventional and Alternative

Looking at the Standard of Care for Cancer Treatment

Report Shows Conventional Cancer Treatment Centers - Worst SEER Statistical Scores

There is a much understandable fear surrounding cancer treatment. Much of this stigma comes from poor results, standardized treatment plans, abysmal side effects, relatively no customization, disease recurrence, and of course, the eventual loss of life.

A major shortcoming of traditional cancer treatment is its singular focus on tumor "response" or shrinkage. In fact, research has shown "response" does not necessarily correlate to increased survival time in adults.

When we are privy to information that a traditional cancer treatment has had a 20% or 30% success rate with late-stage cancer, in actuality that means patients have only experienced a 20-30% "response" rate, or tumor shrinkage. This statistically has little or nothing to do with the patients' quality of life or survival time. In our educated opinion, this misconception is largely responsible for the poor results found in the NCI Surveillance, Epidemiology, and End Results Program (SEER) database report. The SEER web site can be accessed at

A Deeper Look at SEER Trends in Conventional Cancer Centers

Some cancer centers are posting how "their results are notably better" than the conventional system or SEER numbers. That is not difficult to achieve, particularly as it applies to late stage or Stage 4 cancers.

Doctors Faguet and Morgan* have clearly demonstrated that chemotherapy is only 2% effective in the treatment of late-stage and Stage 4 cancer, for a 5-year survival period or beyond. For this primary reason, most facilities do not dare report beyond 2-3 years, let alone 5 beyond initial diagnosis - quite simply the results are not going to pass muster.

Just to provide some perspective, Envita's typical patient is entering our medical center 2-3 years after initial diagnosis and is often refractory to conventional and many times refractory to several alternative therapies. For this reason, Envita is extremely qualified to advance those treatments that are truly "statistic beaters" for patients. It is our contention that the earlier patients incorporate them into their individual treatment plans, the more likely the chance for exponential improvements to manifest beyond statistical expectations. Hereunto forward, all data discussed will be for Stage 4 cancers.

Please note that the percentages provided in the following chapters are estimates (approximates) and not exact, as each patient is atypical and may not respond to a particular conventional or alternative treatment. Additionally, it should be surmised that various details also impact the improvements to survival outcomes and patient quality of life. The primary purpose of this article is not to survey every treatment offered, rather, to provide some weighty examples… clear perspective as well as some definitive bearings by which to assist throughout the information gathering process.

Part I conventional Chemotherapy

Outperforming SEER Numbers through Enhanced Conventional Treatments with Chemotherapy - 75% Improvement for Most Cancers

At Envita, we pride ourselves on providing state-of-the-art conventional and advanced alternative medicine for cancer - aptly titled "integrative" medicine. Two of the most common conventional therapies are chemo and radio (radiation.)

By the time most patients present at Envita, they are either fearful of, or turned off, by these traditional treatment protocols, by and large, because of their own negative experiences. And while Envita has options to help patients abdicate these treatments - chemotherapy and radiation can play both important and effective roles when used minimally - not as the singular treatment.

Second Method to Outperform SEER Numbers with Chemotherapy Cancer Treatment

Chemotherapy is widely used by the famous and most recognized hospitals as a staple for cancer treatments. However, the protocols they follow are derived from large group averages. The resultant problem with this model is that our genetic and molecular testing on Stage 4 cancer shows that 75% of patients were clearly administered an ineffective chemotherapy - one wholly inappropriate for their specific cancer genetics and metabolism.

As a result, these patients suffer needlessly with insidious side effects, compromised quality of life, and substandard results, all while their statistics spiral dangerously downward.

Moreover, these patients were likely being assured, while undergoing treatment that their chemotherapy was working (at least in the short-term) or having a "response." Really all the treatment had rendered was making the cancer and tumor excessively resistant.

By correctly utilizing Envita's comprehensive strategy and implementing genetic and molecular profiling, we immediately observe major improvements in drug choices and a quantum leap toward overall superior, long-term effectiveness. To what particular degree? Roughly a 40% boost to statics across the board.

We envision a future where this will be the realized method by which chemotherapy will be administered. In the meantime, while pharmaceutical companies and politics have an effective stronghold, unfortunately we shall continue to see the business machine satisfied to sell huge quantities of ineffective drugs for Stage 4 cancers - maintaining the game of large protocols as the standard.

Quick 40% Average Increase with Genetic and Molecular Profiling in Cancer Treatment

The second major problem with chemotherapy comes hand in hand with the all-too-typical practice of immediately administering huge doses - rather than the more practical and effective technique calling for low micro doses using insulin potentiation. By directly targeting the specific cancer cells in such manner, it is possible to achieve maximum benefit while minimizing undesirable side effects. Envita's proprietary technique, GTF (genetically targeted Fractioned Chemotherapy), pairs molecular genetic testing and the cancer cells sugar metabolism to pinpoint them directly.

The satisfactory end result prompts fewer side effects coupled with a considerably higher quality of life and a greatly enhanced opportunity for long-term survival.

GTF Can Provide 75% Improvement in Overalls Quality of and Survival Time for Stage 4 Cancer Patients

GTF can provide a 75% overall average improvement over the SEER report for Stage 4 cancers, ensuing 3 years after initial diagnosis. At Envita, we customarily accept patients from 2-3 years, post-diagnosis, as most are channeled through standard methods until they have personally authorized them to be unsatisfactory.

Part II Conventional Radiation treatment

Outperforming SEER Numbers by 75-80% with Newest in Conventional Radiation Cancer Treatment

Generally speaking, radiation treatment tends to be the most misunderstood therapy treatment. Lack of understanding contributes to dismal cancer patient statistics at all stages.

There are two main areas to understand with radiation:

1. Radiation therapy is often improperly prescribed because the surgeon or other care provider uses their personal treatment method - oftentimes one that is cancer approved, but not necessarily optimum for the patient. Consider, for a moment, a scenario where a prostate cancer patient would be prescribed robotic surgery or radiation seed therapy when, in retrospect, (if size and location are appropriate) they would respond better overall to cyber knife radiation. This non-invasive technique could provide life-changing results and be completed with no serious down time or side effects.

If patients were ignorant of all their options they would likely have been faced with the standard several weeks of prescribed recovery that comes with the robotic surgery, including the plausibility of sufferable complications. Moreover, this was only an example of an obvious, early stage cancer with many possibilities for remission. Imagine the outcome if all the genuine options were not weighed in a case of Stage 4 cancer planning - it could be far worse than the extra two weeks in bed and horrendous discomfort. In fact, it could prove lethal.

It should also be related that cyber knife decreases the chance of metastasis due to the absence of surgical removal. As radiation technology improves dramatically, the aim is to marginalize the tumor(s) without administering an abundance of whole-body radiation while keeping the immune system intact. When authorized correctly, extension of life and its quality therewith, can dramatically change a Stage 4 statistic - particularly when combined with essential targeted immunotherapy. At Envita, we have seen such methodology render remissions, even in late-stage disease.

2. Radiation can be an expensive proposition for a hospital or satellite cancer groups. If they own the equipment and a billing code, they will use justify its importance. This therapy type is among the most profitable for cancer hospitals and it was estimated that Cancer Centers of America issues statements - as much as 600 million every 6 months in tomotherapy alone.

However, just because a hospital owns a particular machine or device, it does not necessarily mean it is ideal for a particular patient's condition. Rather, what we see instead are patients being administered treatments without being provided superior options that may, in fact, be available.

It is indisputable that the wrong radiation can cause errant side effects and a significant decline in immune function. In Stage 4 cancer, such result can be devastating.

At Envita, we have top radiation oncology consultants, and access to all the latest technology in targeted, next-generation, radiation therapy including tomothearpy, cyber knife, and proton beam without being fiscally stressed. That provides Envita the luxury of placing patients first, and having the ability to incorporate properly timed immunotherapy to accentuate results.

Should radiation be indicated at Envita, it is completed with definitive plans to eradicate tumors quickly with the lowest possible total body doses, thereby leaving the immune system intact. Historically, we have aided many patients to avoid surgery in early disease stages while decreasing the risk of metastasis and traumatic side effects. The precision of modern-day equipment is accurate within 1mm and with virtually no collateral damage.

At Envita, we implement a truly integrative and advanced approach to cancer treatment. Correct combinations are critical to encourage patients and to improve their overall outcomes.

A Look at Improving Statistical Outcomes with Alternative Cancer Centers

Simply stated, Envita Medical Centers is among (if not the most) advanced alterative cancer treatment centers in the world. Our proprietary alternative medicine methods and treatments make all the difference in improving statistics across the spectrum. We can help you evaluate what is best for your specific condition.

So what is ultimately the best way to compare alternative cancer centers disregarding easily skewed statistics? To begin, it is wise to determine if their focus is committed to improving quality of life and survival for their patients.

How Vitamin C and Ozone Therapy as Cancer Treatments Can Enhance Statics: Up to 70% Life Quality, 50% Survival Time

Oxidative therapies should be staples in the treatment of many cancers. However, only alternative medical centers internationally take advantage of them. Vitamin C works on many levels as a natural form of chemotherapy and, when aided with ultraviolet light, can significantly improve the action on other conventional treatments by increasing reactive oxygen species.

To study more about these therapies, please visit our peer reviewed vitamin C and Ozone articles.

Overview - Why Vitamin C Oxidative Therapies Don't Always Work as Cancer Treatment

At Envita, we offer our own speed drip technology and sustained release intravenous Vitamin C delivery demonstrated to dramatically outperform all others. One Envita treatment is roughly 4 times more therapeutic.

However, there are several reasons that oxidative therapy might improve all patients - at least initially. Some tumors produce larger amounts of enzyme catalase, preventing the beneficial oxidizing effect of hydrogen peroxide produced by high-dose Vitamin C. This can widely be remedied by initially administering ozone therapy, thereby increasing Vitamin C efficacy.

The other issue that bars the way of oxidative therapy results stems from not having enough oxygen outside the cell for the Vitamin C to produce toxic hydrogen peroxide on the tumor. Again, by using ozone properly, prior to the Vitamin C dosing, this obstacle may, in fact, be corrected.

With this approach, it is possible for some patients to realize and maintain remission.

Recognizing Who's Who in the World of Cancer Treatments by What Else - Their Treatments

You need not look beyond the treatments a center offers (and the scope and range of their specialists) to determine why they may (or may not) obtain desirable results. Once you have, you are better equipped to evaluate your options.

Chemotherapy Sensitivity Screening and Target Radiation

Treatments provided by hospitals and cancer centers that authorize mammoth advertising campaigns are usually limited to their own equipment. They may access old or new - but will use them liberally, as long as they have their own billing codes.

At Envita, we provide patients with a full spectrum of options - the most effective and advanced, known to mankind. We personalize and tailor your treatment to help you and even choose to limit chemotherapy and radiation - administering only when needed, as there are many other tools available to enhance results. In simple terms, we are the alternative medicine authorities.

Other Alternative Therapies Being Researched as Cancer Treatments

Most alternative centers offer a high-dose Vitamin C treatment to their patients. Some may also administer ozone therapy, depending on their state and licensure. Those are always good to parse from the onset.

However, during your search, you may run note phrases like mistletoe treatment, Resveratrol treatment, Sodium Bicarbonate treatments, and myriad supplements and teas. And while many of these adjunct therapies mentioned may have their place with correct application and setting, ultimately not one of them has been a savior.
Envita has been exposed to so many therapies, we are utterly confident that our personalized approach of combining idyllic treatment combinations with passionate physicians, is the key to achieving significant results - really advancing the statics in your favor.

Deeper Look at Alternative Medicine Cancer Treatment Centers with Immunotherapy

A clever method to evaluate Alternative Cancer Treatment Centers is by determining the level of immunotherapy available at each given center. Here is a solid explanation of immunotherapy's tier levels that may be applied to such comparative analysis.

Entry Level immunotherapy- This is observed at most naturopathic medical practices, Chiropractic offices, acupuncture operations, and health food establishments and is most easily recognized by the administering of immune system building oral supplements, essential nutrition, and teas. The level of background in cancer immunotherapy can vary greatly among these providers. Nevertheless, you will find that entry level is what is most often used in combination with chemotherapy and radiation. While it does have some obvious positive effects, it is typically offered to demonstrate a particular practice or institution apparent open mindedness while remaining focused on pharmaceutical-based solutions.

Middle Level immunotherapy- Administers forms of immunotherapy like intravenous high-dose Vitamin C for cancer patients. Iscador, mistle toe, Resveratrol, Sodium Bicarbonate and other homeopathic botanicals may also be included in their treatment protocols. Oftentimes, middle level is provided by Naturopathic doctors in some states, as well as by some more open-minded MDs and DOs. These middle level practices will augment some entry level methods as well.

Higher Level immunotherapy- Aims to potentiate various forms of chemotherapy via immunotherapy. Their providers (Dos or MDs) carry the licensure essential to practice these methods and will likely integrate all methodologies mentioned above. Their goal is to target cancer cells while working to get the immune system functioning at a potentially high level.

Highest Level immunotherapy- This method refers directly to the science of building vaccines derived from the patient's own immune system to fight cancer. Cellular-based immunotherapy extracts white blood cells and expands them to more effectively override the disease. This is akin to an "immune system transplant" of sorts and originated some 25 years ago with cytotoxic T cells. The science and methodology of this highest level continue to advance rapidly and are greatly available in countries outside the shores of The United States. That said, a newly approved drug has just been accepted in the United States for Stage 4 prostate cancer patients.
Next Gen Immunotherapy- This is a Cellular-based immunotherapy founded upon genetic manipulation.

All methods of immunotherapy are currently offered at Envita international medical centers. And with those therapies we have the experience and training to determine ideal combinations in particular case-by-case scenarios.

What Most Oncologists Consider Immunotherapy and the Important Alternatives They Ignore

Cell-based immunotherapy is typically recognized domestically when a drug trial is being sponsored. By and large however, the science is typically ignored. While cytokines are referenced, conventional treatment centers continually leave them out of cancer protocols. It seems that conventional oncologists worry that their patient will be taken off normal chemotherapy treatments for an unproven radical alternative. This unfounded fear stands in the way of most patients fully engaging in the best treatment plan possible to battle their disease.

Stacking the Statics in Your Favor

Natural Killer Cells Treatment and Technology

Envita's proprietary natural killer cell cancer vaccine (AAIT) is a highly efficacious treatment, providing a uniquely targeted way to eradicate cancer - in particular, metastatic disease. You can learn more about AAIT on Envita's AAIT Cancer Vaccine page.

Please note, Envita's international centers provide abundant treatments yet to be made available in the U.S.

The Real Goal in Any Cancer Treatment is Long Term Remission

Most of us continue to become more educated and aware as we are faced with an endless barrage of marketing and advertising campaigns to link us to myriad products and services. For obvious reason, when we assess the medical industry, we tend to assume that they are above such practices of miscommunication and manipulation.
However, when billions of dollars are at stake, direct corners are cut and data is often manipulated. No doubt, we agree that doctors strive to heal their patients, but that does not mean that the institution that issues their check isn't ultimately motivated by the almighty dollar - something that can corrupt and contaminate the general environment of care.

In other words, do not be misled. Your life cannot be devalued.

In conventional cancer treatment models, "await results" has become a far too common approach. After treatment is administered, patients wait to assess if their bodies respond to treatment - and how long the effects will last.

Oncologists use the term "remission" and not "cure," because it is unknown whether the cancer will resurface. There still may be cancer cells remaining in the body, even though there is apparent sign of it at the time. These cancer cells, which can conquer dormancy, often account for the recurrence of disease.

At Envita, we wish to initiate the best personalized treatment plan for you or your loved ones by using the most targeted and comprehensive approaches from around the world.

No matter which eventual route you chose, we wish to personally welcome you to Envita Medical Centers and let you know we are here for you throughout your journey to wellness- the uncontested leaders in personalized cancer treatment. At Envita, we aim to continually set the bar for improving cancer statistics - one patient at a time.

Older Post Newer Post

Leave a comment

Please note, comments must be approved before they are published